Agilent Technologies Inc (A)
NYSE · Healthcare · Diagnostics & Research
Agilent Technologies Inc is a Healthcare company with a market capitalization of $38.41B, a trailing P/E ratio of 27.3, and a dividend yield of 0.74%.
5-Year Price History
Latest Annual Financials · FY ending October 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | May 27, 2026 | $1.49 | $1.41 | +5.7% |
| Q1 2026 | February 25, 2026 | $1.07 | $1.24 | -13.7% |
| Q4 2025 | November 24, 2025 | $1.59 | $1.58 | +0.6% |
| Q3 2025 | August 27, 2025 | $1.37 | $1.37 | +0.0% |
| Q2 2025 | May 28, 2025 | $1.31 | $1.26 | +4.0% |
| Q1 2025 | February 26, 2025 | $1.31 | $1.27 | +3.1% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Agilent Technologies Inc's market cap?
As of June 29, 2026, Agilent Technologies Inc (A) has a market capitalization of $38.41B.
What is Agilent Technologies Inc's P/E ratio?
Agilent Technologies Inc trades at a trailing price-to-earnings (P/E) ratio of 27.3. Its forward P/E is 22.4.
Does Agilent Technologies Inc pay a dividend?
Yes — Agilent Technologies Inc pays a dividend yielding 0.74%, an annual payout of $1.01 per share.
What sector is A in?
Agilent Technologies Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Agilent Technologies Inc's revenue?
In its latest reported fiscal year (ending October 31, 2025), Agilent Technologies Inc reported revenue of $6.95B and net income of $1.30B.
Ask your own questions about A
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.